JP
Insider selling
Jason P Rhodes sold $5.6M of Dyne Therapeutics, Inc. (DYN) stock
Jason P Rhodes, Dir of Dyne Therapeutics, Inc. (DYN), sold 267,760 shares of DYN stock worth $5.6M, per an SEC Form 4 filed Jun 26, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 23, 2026, 3 days before it was made public.
DYN has moved -15.5% since the trade date, from $20.26 to $17.12 (Sep 21, 2026 close).
- Traded
- Jun 23, 2026
- Disclosed
- Jun 26, 2026
- Filing delay
- 3 days
- Price since
- -15.5%
- Role
- Dir
- Source
- SEC Form 4
More DYN insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.